Intrathecal Mg in Gynecologic Laparoscopic Surgeries.

Assiut University

Status and phase: Completed; Phase 2

Conditions: Gynecologic Laparoscopic Surgery

Treatments: Drug: intrathecal Mg sulfate.; Drug: intrathecal bupivacaine 15 mg.

Study type: Interventional

Funder types: Other

Identifiers

NCT02671227

intrathecal Mg in gyne. lap.

Details and patient eligibility

About

The investigators aim to investigate the differences between intrathecal Bupivacaine + Mg sulfate in spinal anesthesia versus Bupivacaine on surgeon satisfaction and postoperative pain in gynecologic laparoscopic surgeries.

Full description

The investigators aim to investigate the differences between intrathecal Bupivacaine + Mg sulfate in spinal anesthesia versus Bupivacaine on surgeon satisfaction, patient satisfaction and postoperative pain in gynecologic laparoscopic surgeries.

Enrollment: 50 estimated patients

Sex: Female

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• female patient.
• more than 18 years.
• undergoing elective gynecologic laparoscopic surgeries.

Exclusion criteria

• allergy to local anesthesia.
• contraindication to spinal anesthesia.
• Significant cardiac, liver or renal dysfunction.
• Inability to informed consent

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

50 participants in 2 patient groups

intrathecal bupivacaine + Mg sulfate

Active Comparator group

Description:

intrathecal bupivacaine 15 mg + intrathecal Mg sulfate 50 mg. in gynecologic laparoscopic surgeries.

Treatment:

Drug: intrathecal Mg sulfate.

Drug: intrathecal bupivacaine 15 mg.

intrathecal bupivacaine

Active Comparator group

Description:

intrathecal bupivacaine 15 mg in gynecologic laparoscopic surgeries.

Treatment:

Drug: intrathecal bupivacaine 15 mg.